Patent 9446003 was granted and assigned to Abraxis BioScience on September, 2016 by the United States Patent and Trademark Office.
The present invention provides prion-free compositions comprising nanoparticles comprising albumin and substantially water insoluble drugs. Also provided are methods of making prion-free compositions and methods of removing prion proteins from the nanoparticle compositions. Methods of using the compositions, as well as kits useful for carrying out the methods are also provided.